Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Rheumatic Diseases Clinics of North America|June 18, 2023
The Role of Imaging in Diagnosis and Monitoring of Large Vessel VasculitisAudra Horomanski, Lindsy J ForbessACR Open Rheumatology|July 6, 2024
Increased Risk of Preterm Delivery Subtypes and Hypertensive Disorders of Pregnancy in First Deliveries of Patients With Systemic VasculitisAudra Horomanski, Jonathan Mayo, Gary M Shaw, et al.The Lancet. Rheumatology|October 20, 2025
Pregnancy outcomes in patients with systemic vasculitis in the USA from 2007 to 2022: an administrative claims-based studyAudra Horomanski, Amadeia Rector, Gary M Shaw, et al.The Lancet. Rheumatology|January 22, 2024
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trialVibeke Strand, David R W Jayne, Audra Horomanski, et al.JACC. Case Reports|August 15, 2025
Successful Rituximab Treatment of GPIHBP1 Autoantibody-Associated HypertriglyceridemiaTasmeen Hussain, Audra Horomanski, Sneha Jain, et al.Seminars in Arthritis and Rheumatism|June 18, 2021
Ultrasound evaluation of the hands and wrists in patients with systemic sclerosis: Osteophytosis is a major contributor to tender jointsRobert Fairchild, Audra Horomanski, Laurel Sharpless, et al.BMJ Open Respiratory Research|August 13, 2021
Prevalence and significance of pulmonary disease on lung ultrasonography in outpatients with SARS-CoV-2 infectionRobert M Fairchild, Audra Horomanski, Diane A Mar, et al.ACR Open Rheumatology|June 14, 2023
Biologics Initiation in Rheumatoid Arthritis by Race and Ethnicity: Results From a Randomized Survey StudyJulia F Simard, Rong Lu, Titilola O Falasinnu, et al.Rheumatology (Oxford, England)|July 20, 2023
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosisMatthew C Baker, Audra Horomanski, Yiwen Wang, et al.Frontiers in Neurology|March 13, 2023
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinicHector Bonilla, Tom C Quach, Anushri Tiwari, et al.Pageof 2